CSG's Half-Year Report Card: A €1.2 Billion Working Capital Squeeze Overshadows Robust Operational Gains
Published on 08/10/2026 at 10:50 | Redaktion boerse-global.de
The arithmetic of CSG's first-half performance tells a straightforward story of double-digit growth — yet the market's verdict on Friday was anything but straightforward. The Dutch defence group's shares slid 6.83 percent to close at €18.11, a pullback that came despite revenues climbing 17.2 percent to €3,251 million and operating profit advancing 12.7 percent to €784 million. The disconnect between the headline numbers and the share price reaction points to a balance sheet dynamic that investors found harder to digest.
The stock's retreat on Friday — the secondary source records a marginally different decline of 6.88 percent to €18.10 — needs context. Over the preceding 30 days, CSG had surged roughly 32.5 percent, so some profit-taking after a powerful run was arguably inevitable. Even after the setback, the shares remain nearly 50 percent below the 52-week high of €36.05 touched in late January, underscoring how volatile this name has become. With annualised 30-day volatility at 64.30 percent, CSG ranks among the riskier equities in the European defence space.
The Working Capital Question
The operational highlights were, by any measure, solid. The EBIT margin held at 24.1 percent, comfortably within management's guided range, and the company reaffirmed its full-year revenue forecast of €7.4 billion to €7.6 billion with an EBIT margin between 24 and 25 percent. But the real story — and the likely trigger for the share price weakness — sat on the other side of the ledger.
CSG's working capital ballooned by €1.2 billion, a build-up that weighed heavily on free cash flow and pushed net debt to €2,914 million. The leverage ratio now stands at 1.6 times operating EBITDA, well above the year-end target of under 1.3. Management attributes the increase primarily to strategic stockpiling of components for medium- and large-calibre ammunition — a deliberate bet on securing supply chains ahead of production ramp-ups. The expectation is for inventories to unwind in the second half, particularly in the fourth quarter, with net working capital guided to finish the year below 20 percent of sales.
That explanation carries weight given what CSG is trying to build. The company plans to lift in-house production of large-calibre ammunition to roughly 850,000 rounds by the end of 2026, up from 550,000 in 2025 — a jump that depends directly on the component stockpiling now underway. Further targets include manufacturing 60 percent of long-range ammunition internally by year-end, starting production of the Karpat battle tank in the first quarter of 2027, and achieving full vertical integration by the end of 2027.
Land Systems Emerges as the Growth Engine
The strategic pivot towards land-based defence is paying off in the order book. The Land Systems division doubled its revenue year-on-year to €445 million and now accounts for 46 percent of the group's total order backlog of €17 billion. Equally notable is the shifting customer mix: Ukraine's share of revenue has fallen from 27 to 17 percent, with NATO markets filling the gap — a rebalancing that reduces geopolitical concentration risk while aligning CSG more closely with the procurement priorities of Western alliances.
An Industrial Footprint Expanding on Multiple Fronts
The expansion programme gathered pace across several geographies in recent weeks. On 4 August, CSG completed the acquisition of the 57-hectare Gnaschwitz industrial site in Saxony from Maxam, with plans to invest more than €100 million in developing a defence technology hub there, initially focused on nitroglycerin production and munitions manufacturing. A day later, the group took a minority stake in North Vector Dynamics, a Canadian developer of precision-guided missiles, counter-drone systems and hypersonic technology; the Canadian company is now valued at over $90 million, though the price CSG paid remains undisclosed.
Managing hazardous substances safely is a core part of any industrial operation. A free COSHH toolkit provides 43 customisable templates, checklists and toolbox talks to help you meet your legal duties for assessing risks from dangerous substances. Download the free COSHH Toolkit
Across the Atlantic, construction began in mid-July on the "Future Artillery Complex" at the Iowa Army Ammunition Plant, a $635 million project. Earlier that month, CSG established CSG Land Systems North America with a new headquarters in Washington, D.C., signalling a more deliberate push into the US market. The group also transferred core propellant production technology to Polish manufacturer MESKO in July to expand its ammunition output.
Unmanned systems are another frontier. Late July saw the launch of MAIA, a digital airspace management and drone tracking platform developed by subsidiary UpVision, followed days later by the announcement of a new technology centre in the Czech Republic focused on propulsion systems for unmanned aerial vehicles in partnership with AviaNera.
Fresh Leadership at the Top
Ben Hudson joined CSG's board as vice-chair on 1 August, bringing more than three decades of defence industry experience. Hudson, who had already been serving as CEO of CSG Land Systems and group CTO since June, previously led Hanwha Europe, UK and Australia, held the group CTO role at BAE Systems, and ran Rheinmetall's vehicle systems division. His appointment adds operational depth at a moment when the group is juggling multiple capital-intensive projects.
With operations expanding across multiple sites, keeping your workplace safety documentation in order is more important than ever. A free Health & Safety toolkit offers ready-to-use risk assessments and checklists covering key UK regulations like COSHH and PUWER, helping you protect employees and visitors alike. Get the free Health & Safety Toolkit
What to Watch Next
Jefferies analyst Chloe Lemarie reaffirmed her buy recommendation with a €25.00 price target following the results, citing the double-digit growth rates and the reaffirmed guidance range. The next test comes on 10 November, when CSG publishes its third-quarter trading update. By then, investors will be looking for evidence that the working capital build is indeed unwinding as promised — and that the heavy investment in Saxony, Iowa, the Czech Republic and North America is translating into firm order intake. For now, the market appears willing to give management the benefit of the doubt, but the cash conversion story will need to improve before the share price fully reflects the operational momentum.
